112 related articles for article (PubMed ID: 10220269)
1. Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection.
Froberg MK; Garg UC; Stroncek DF; Geis M; McCullough J; Brown DM
Transfusion; 1999 Apr; 39(4):410-4. PubMed ID: 10220269
[TBL] [Abstract][Full Text] [Related]
2. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
[TBL] [Abstract][Full Text] [Related]
3. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization.
Watanabe T; Suzuya H; Onishi T; Kanai S; Kaneko M; Watanabe H; Nakagawa R; Kawano Y; Takaue Y; Kuroda Y; Talmadge JE
Int J Hematol; 2003 Jan; 77(1):75-81. PubMed ID: 12568303
[TBL] [Abstract][Full Text] [Related]
5. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.
Anderlini P; Przepiorka D; Seong D; Miller P; Sundberg J; Lichtiger B; Norfleet F; Chan KW; Champlin R; Körbling M
Transfusion; 1996 Jul; 36(7):590-5. PubMed ID: 8701453
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
[TBL] [Abstract][Full Text] [Related]
9. Analysis of apheresis content of progenitor cell collections from normal donors to whom granulocyte-colony-stimulating factor is administered.
Weinthal JA; Nemunaitis JJ; Aston S; Magsamen MJ; Rosenfeld CS
Transfusion; 1996; 36(11-12):943-7. PubMed ID: 8937400
[TBL] [Abstract][Full Text] [Related]
10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor administration: adverse events.
D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
[TBL] [Abstract][Full Text] [Related]
12. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
Heuft HG; Goudeva L; Blasczyk R
Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
[TBL] [Abstract][Full Text] [Related]
15. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone formation in Thai children and adolescents.
Chailurkit LO; Suthutvoravut U; Mahachoklertwattana P; Charoenkiatkul S; Rajatanavin R
Endocr Res; 2005; 31(3):159-69. PubMed ID: 16392618
[TBL] [Abstract][Full Text] [Related]
17. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors.
Lane TA; Ho AD; Bashey A; Peterson S; Young D; Law P
Transfusion; 1999 Jan; 39(1):39-47. PubMed ID: 9920165
[TBL] [Abstract][Full Text] [Related]
19. Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors.
Seong C; Durett A; Mirza N; Huh Y; Anderlini P; Champlin R
Transfusion; 1997 Apr; 37(4):406-10. PubMed ID: 9111278
[TBL] [Abstract][Full Text] [Related]
20. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors.
Pamphilon D; Nacheva E; Navarrete C; Madrigal A; Goldman J
Transfusion; 2008 Jul; 48(7):1495-501. PubMed ID: 18373639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
